Skip to content

Stock-Based Comp at other companies

GLW
CorningGLW
Revvity logo
RevvityRVTY
Mesa Laboratories logo
Mesa LaboratoriesMLAB
Illumina logo
IlluminaILMN
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.21B+17.7%
Enterprise value$249.32B+16.0%
P/E30.8×+3.1×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Thermo Fisher Scientific's stock-based comp?
Thermo Fisher Scientific (TMO) reported stock-based comp of $83M in Q1 2026.
How has Thermo Fisher Scientific's stock-based comp changed year-over-year?
Thermo Fisher Scientific's stock-based comp increased by 10.7% year-over-year, from $75M to $83M.
What is the long-term trend for Thermo Fisher Scientific's stock-based comp?
Over 4 years (2021 to 2025), Thermo Fisher Scientific's stock-based comp has grown at a 7.7% compound annual growth rate (CAGR), from $230M to $310M.